Need help navigating aged care? Explore our support services
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

Dream cure may become reality

If you suffer from Type 1 diabetes or rheumatoid arthritis, then hope may be on its way. International scientists are claiming the dream of reducing – and even eliminating – daily insulin injections may become reality for people with Type 1 diabetes by treating the cause of the debilitating disease, rather than its effects.

If you suffer from Type 1 diabetes or rheumatoid arthritis, then hope may be on its way.

International scientists are claiming the dream of reducing – and even eliminating – daily insulin injections may become reality for people with Type 1 diabetes by treating the cause of the debilitating disease, rather than its effects.

While most research focuses on replacing damaged islets, Professor Young Zhao and his colleagues at Chicago’s University of Illinois, are targeting the defective immune system.

The team used so-called mesenchymal stem cells obtained from human cord blood to “re-educate” misbehaving immune cells, or lymphocytes.

They did so by passing patients’ blood through a “stem cell educator” containing layers of cord blood stem cells for two or three hours then returning it to the patients.

The daily dose of insulin, after a 12 week treatment, was reportedly nearly reduced by 40% in the nine volunteers involved in the study.

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo